Bamboos Health Care Holdings Limited
HKEX:2293.HK
0.64 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 94.787 | 127.814 | 141.398 | 110.801 | 72.318 | 274.5 | 302.718 | 62.476 | 50.966 | 49.251 | 38.403 | 31.35 |
Cost of Revenue
| 10.07 | 50.158 | 50.063 | 28.616 | 33.586 | 196.445 | 221.648 | 15.22 | 12.866 | 11.863 | 7.363 | 6.252 |
Gross Profit
| 84.717 | 77.656 | 91.335 | 82.185 | 38.732 | 78.055 | 81.07 | 47.256 | 38.1 | 37.388 | 31.04 | 25.098 |
Gross Profit Ratio
| 0.894 | 0.608 | 0.646 | 0.742 | 0.536 | 0.284 | 0.268 | 0.756 | 0.748 | 0.759 | 0.808 | 0.801 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 4.049 | 4.931 | 5.226 | 3.661 | 3.923 | 8.966 | 6.472 | 1.386 | 1.56 | 0 | 0 | 6.307 |
Selling & Marketing Expenses
| 0.337 | 0.408 | 0.993 | 0.128 | 0.514 | 0.499 | 1.079 | 1.128 | 0.964 | 0 | 0 | 0.397 |
SG&A
| 4.386 | 0.529 | 1.169 | 0.287 | 7.969 | 9.465 | 7.551 | 10.593 | 9.178 | 1.223 | 0.72 | 1.016 |
Other Expenses
| 39.207 | 0.786 | -0.976 | 0.37 | 2.925 | 1.802 | 3.652 | 4.251 | 0 | 0 | 0 | 0 |
Operating Expenses
| 43.593 | 18.556 | 19.463 | 9.825 | 5.044 | 33.754 | 32.461 | 6.342 | 9.178 | 9.931 | 17.566 | 8.427 |
Operating Income
| 40.722 | 59.856 | 74.087 | 73.177 | 33.688 | 48.168 | 51.873 | 40.914 | 28.922 | 27.555 | 25.677 | 20.298 |
Operating Income Ratio
| 0.43 | 0.468 | 0.524 | 0.66 | 0.466 | 0.175 | 0.171 | 0.655 | 0.567 | 0.559 | 0.669 | 0.647 |
Total Other Income Expenses Net
| -1.493 | -1.171 | -0.722 | 0.303 | 0.036 | -1.05 | -0.906 | 0.264 | 3.566 | -0.212 | -0.372 | -0.336 |
Income Before Tax
| 39.229 | 58.674 | 72.437 | 73.48 | 36.176 | 47.118 | 50.967 | 39.786 | 32.488 | 27.245 | 13.102 | 16.335 |
Income Before Tax Ratio
| 0.414 | 0.459 | 0.512 | 0.663 | 0.5 | 0.172 | 0.168 | 0.637 | 0.637 | 0.553 | 0.341 | 0.521 |
Income Tax Expense
| 8.31 | 11.755 | 13.817 | 12.458 | 5.486 | 8.198 | 8.746 | 7.175 | 5.646 | 4.858 | 4.403 | 3.269 |
Net Income
| 30.919 | 46.919 | 58.62 | 61.022 | 30.691 | 38.92 | 42.221 | 32.611 | 26.842 | 22.387 | 8.699 | 13.066 |
Net Income Ratio
| 0.326 | 0.367 | 0.415 | 0.551 | 0.424 | 0.142 | 0.139 | 0.522 | 0.527 | 0.455 | 0.227 | 0.417 |
EPS
| 0.077 | 0.12 | 0.15 | 0.15 | 0.077 | 0.097 | 0.11 | 0.082 | 0.067 | 0.056 | 0.029 | 0.044 |
EPS Diluted
| 0.077 | 0.12 | 0.15 | 0.15 | 0.077 | 0.097 | 0.11 | 0.082 | 0.067 | 0.056 | 0.029 | 0.044 |
EBITDA
| 52.758 | 71.056 | 81.318 | 78.045 | 42.707 | 47.949 | 52.396 | 41.4 | 29.448 | 28.168 | 26.16 | 20.71 |
EBITDA Ratio
| 0.557 | 0.479 | 0.533 | 0.674 | 0.546 | 0.156 | 0.163 | 0.663 | 0.578 | 0.572 | 0.681 | 0.661 |